Technology area: Biotechnology & Pharmaceuticals
25 pending office actions • 14 clients • 23 examiners • 23 art units • 0 of 25 (0%) have an AI response strategy ready
Berg Hill Greenleaf & Ruscitti LLP has 1,021 career applications and 26 pending office actions in Biotechnology & Pharmaceuticals. The profile combines a substantial application history with an active docket in a field where prosecution often depends on precise technical and claim-focused responses.
Its resolved allowance rate is 84.38%, and the average is 3.44 office actions per allowance. These figures should be read together but not as substitutes: the rate describes resolved allowance outcomes, while the average describes examination effort for allowed matters. Practitioners can use the combination to frame portfolio expectations, then examine the relevant biological subject matter and pending-action posture in detail.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (16%) |
| §103 only | 4 (16%) |
| §102 only | 2 (8%) |
| §112 only | 3 (12%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 11 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEAMAN, D MARGARET M | 2 | 76.6% | +8.1% |
| KOVALENKO, MYKOLA V | 2 | 69.6% | +25.5% |
| DEVEAU ROSEN, JASON | 1 | 80.0% | +16.3% |
| WEBER, JONATHAN C | 1 | 64.7% | +28.3% |
| HOGE, GARY CHAPMAN | 1 | 63.6% | +22.7% |
| NGUYEN, TRUNG Q | 1 | 91.0% | +6.2% |
| SHEN, YANXIN NMN | 1 | 84.6% | +26.4% |
| BEZUAYEHU, SOLOMON G | 1 | 75.7% | +29.2% |
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.0% |
| RILEY, JEZIA | 1 | 83.0% | +7.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17962656 | Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof | SEAMAN, D MARGARET M | 60d overdue |
| 17913528 | PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF | SEGED, NEBYATE SAMUEL | 42d overdue |
| 18787496 | COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF | RODRIQUEZ, KARI KRISTIN | 15d overdue |
| 18925427 | HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS | SHEN, YANXIN NMN | 9d |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 19d |
| 19020100 | ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF | HOGE, GARY CHAPMAN | — |
| 18865231 | SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS | NGUYEN, TRUNG Q | — |
| 18847671 | METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS | SAIDHA, TEKCHAND | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17189063 | Compositions And Methods For Glycosylating Cannabinoid Compounds | KOVALENKO, MYKOLA V | 11d overdue |
| 18925427 | HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS | SHEN, YANXIN NMN | 9d |
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
| 19262061 | METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE | WEBER, JONATHAN C | — |
| 19020100 | ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF | HOGE, GARY CHAPMAN | — |
| 18854492 | SYSTEM, DEVICE AND METHOD FOR PLANT IDENTIFICATION AND SPRAY CONTROL | BEZUAYEHU, SOLOMON G | — |
| 18847671 | METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS | SAIDHA, TEKCHAND | — |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | — |
| Art Unit | Apps |
|---|---|
| 1662 | 3 |
| 3641 | 1 |
| 3631 | 1 |
| 2858 | 1 |
| 1629 | 1 |
| 1663 | 1 |
| 2674 | 1 |
| 1652 | 1 |
| 1681 | 1 |
| 3651 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | Trait Biosciences, Inc. | DEVEAU ROSEN, JASON | 1662 | §112 | Non-Final OA | — | Pending | Aug 05, 2025 |
| 19262061 | METHOD FOR MANUFACTURING AN AMMUNITION CARTRIDGE AND AMMUNITION CARTRIDGE | Serviço Nacional De Aprendizagem Industrial - Departamento Regional Do Rio Grande Do Sul - Senai/Rs | WEBER, JONATHAN C | 3641 | §102 | Final Rejection | — | Pending | Jul 07, 2025 |
| 19020100 | ORNAMENTAL DISPLAY AND METHODS OF USE THEREOF | Balloon Innovations, Inc. | HOGE, GARY CHAPMAN | 3631 | §102§103 | Non-Final OA | — | Pending | Jan 14, 2025 |
| 18865231 | SYSTEM AND METHOD FOR MONITORING THE OPERATING CONDITION OF ROTATING ELECTRICAL MACHINERY AND AUTOMATIC DETECTION OF MECHANICAL AND ELECTRICAL FAULTS | 2Neuron Solucoes Em Inteligencia Artificial Ltda | NGUYEN, TRUNG Q | 2858 | §101§103§112 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18864247 | ANTIBIOTIC COMPOSITION AND METHODS OF USE THEREOF | The Regents of the University of Colorado | SEAMAN, D MARGARET M | 1629 | §103 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18925427 | HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS | The Regents of the University of Colorado | SHEN, YANXIN NMN | 1663 | §103§112 | Non-Final OA | 9d | Pending | Oct 24, 2024 |
| 18854492 | SYSTEM, DEVICE AND METHOD FOR PLANT IDENTIFICATION AND SPRAY CONTROL | Eirene Projetos E Consultoria Ltda | BEZUAYEHU, SOLOMON G | 2674 | §103 | Final Rejection | — | Pending | Oct 04, 2024 |
| 18847671 | METHODS AND COMPOSITIONS FOR DISRUPTING TAU AGGREGATES USING POLYSERINE REPEAT SEQUENCES TARGETING EXOGENOUS PROTEINS | The Regents of the University of Colorado | SAIDHA, TEKCHAND | 1652 | §102§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18800335 | SYNTHESIS OF BACKBONE MODIFIED MORPHOLINO OLIGONUCLEOTIDES AND CHIMERAS USING PHOSPHORAMIDITE CHEMISTRY | The Regents of the University of Colorado | RILEY, JEZIA | 1681 | §102§103§112Other | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18799172 | BALL COLLECTION APPARATUS AND METHODS OF USE THEREOF | Buchner Enterprises Inc. Dba Caddie Buddy | GIOMMI, ALEXANDER PAUL | 3651 | §102§103 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18787496 | COMPRESSIVE ORTHOTIC DEVICE AND METHODS OF USE THEREOF | Quorum Orthopedics, Inc. | RODRIQUEZ, KARI KRISTIN | 3786 | §101§102§103§112 | Non-Final OA | 15d overdue | Pending | Jul 29, 2024 |
| 18769097 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC | ROBERTS, LEZAH | 1612 | §103 | Final Rejection | — | Pending | Jul 10, 2024 |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | Trait Biosciences, Inc. | FETTEROLF, BRANDON J | 1626 | §102§112 | Non-Final OA | — | Pending | May 30, 2024 |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | Trait Biosciences, Inc. | KOVALENKO, MYKOLA V | 1662 | §103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18291686 | COMPACT CENTRIFUGAL MIXING DEVICE AND METHODS OF USE THEREOF | Flacktek Speedmixer, Inc. | BHATIA, ANSHU | 1774 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18533935 | CELL IMAGING AND COMPRESSION SYSTEM AND METHODS OF USE THEREOF | Georgia Tech Research Corporation | LYLE, SOPHIA YUAN | 1796 | §103§112 | Final Rejection | — | Pending | Dec 08, 2023 |
| 18364273 | WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY | Trait Biosciences, Inc. | MOEHLMAN, ANDREW TERRY | 1655 | §102§103§112DP | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18020335 | ELECTROCHEMICAL MICROFLUIDIC ASSAY DEVICES | Colorado State University Research Foundation | MUI, CHRISTINE T | 1797 | §102 | Final Rejection | 70d overdue | Pending | Feb 08, 2023 |
| 17962656 | Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof | The Regents of the University of Colorado | SEAMAN, D MARGARET M | 1625 | §102§112 | Final Rejection | 60d overdue | Pending | Oct 10, 2022 |
| 17913528 | PHOTO REACTOR DEVICES, SYSTEMS, AND METHODS OF USE THEREOF | Colorado State University Research Foundation | SEGED, NEBYATE SAMUEL | 1758 | §103§112 | Non-Final OA | 42d overdue | Pending | Sep 22, 2022 |
| 17822992 | Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS) | The Regents of the University of Colorado | NOAKES, SUZANNE MARIE | 1656 | §112 | Final Rejection | 28d overdue | Pending | Aug 29, 2022 |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD | TAYLOR, LIA ELAN | 1641 | §101§112 | Final Rejection | 19d | Pending | Feb 18, 2022 |
| 17603276 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | Nature'S Toolbox, Inc. | SMALL, KATHERINE R | 1633 | §103 | Non-Final OA | 77d overdue | Pending | Oct 12, 2021 |
| 17189063 | Compositions And Methods For Glycosylating Cannabinoid Compounds | Trait Biosciences, Inc. | KOVALENKO, MYKOLA V | 1662 | §112 | Final Rejection | 11d overdue | Pending | Mar 01, 2021 |
| 17266502 | PARN AS A BIOMARKER AND THERAPEUTIC TARGET | The Regents of the University of Colorado | TRAN, CHRISTINA L | 1637 | §101§103§112Other | Non-Final OA | — | Pending | Feb 05, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial84.4% of resolved applications prosecuted by Berg Hill Greenleaf & Ruscitti LLP were allowed, across 1,021 applications in USPTO records.
3.44 office actions per allowed application on average.
25 pending office actions as of October 2026, for 14 clients, before 23 examiners in 23 art units.